中文 | English
Return
Total: 22 , 1/3
Show Home Prev Next End page: GO
Author:( Lirong HU)

1.hMLH1 promoter hypermethylation correlates with platinum-resistance in non-small cell lung cancer cells

Lirong WU ; Chunhong HU

China Oncology 2006;0(07):-

2.Comparison of clinical pathological characteristics in ovarian preserving patients with stageⅠB1 cervical adenocarcinoma and squamous cell carcinoma

Jun HU ; Peizi ZHENG ; Lirong ZHU

Journal of Peking University(Health Sciences) 2016;48(5):783-787

3.Construction and verification of the prognostic model of ovarian serous adenocarcinoma

Jun HU ; Lirong ZHU ; Qinping LIAO ; Yunong GAO ; Hong ZHENG

Tumor 2010;(2):125-129

4.Clinical value of microsurgery in the treatment of tentorial meningioma

Lirong LI ; Jianwei ZHAO ; Changchen HU ; Junwei LI

Chinese Journal of Primary Medicine and Pharmacy 2013;20(20):3060-3062

5.Prognostic values of tumor-stroma ratio and tumor-infiltrating lymphocytes in stagesⅡandⅢcolorectal cancer

Xi ZHANG ; Bailai HU ; Zhen LV ; Guangzhen MA ; Lirong CHEN

Chinese Journal of Clinical Oncology 2015;46(4):241-246

6. Spatiotemporal image correlation combined with 5D Heart intelligent navigation technique in normal fetal heart screening

Lirong HU

Chinese Journal of Medical Imaging Technology 2019;35(6):872-876

8.Preliminary application of MMSE cognitive assessment in the patients with glioma

Hongming JI ; Changchen HU ; Gangli ZHANG ; Lirong LI ; Guijun JIA ; Peng ZOU

Cancer Research and Clinic 2012;24(5):311-312,315

9.CT manifestation of schistosoma haematobium cystitis

Yujun WANG ; Lirong HU ; Yougen CHENG ; Guoqun MAO ; Guangzhao YANG ; Camara MODYA ; Traore MOHAMED

Chinese Journal of Radiology 2014;48(2):132-134

10.Tetramethylpyrazine inhibition on binding of radiolabeled ligand to VEGFR

Jundong FENG ; Xiaoyu XU ; Yiyong HU ; Gang CHEN ; Weihai CHEN ; Lirong YANG

Chinese Pharmacological Bulletin 2003;0(08):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 22 , 1/3 Show Home Prev Next End page: GO